peanut immunotherapy epicutaneous (Pending FDA Approval)

Brand and Other Names:Viaskin Peanut
  • Print

Dosing & Uses

AdultPediatric

See Pediatric Dosing

Peanut Allergy

Pending FDA approval for epicutaneous desensitization to protect peanut allergic patients from severe reactions who are accidentally exposed to peanuts

Next:

Pharmacology

Mechanism of Action

Epicutaneous immunotherapy for gradual desensitization and maintenance to protect peanut allergic individuals in case of accidental exposure

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.